For IV NAD+, a clinical provider will handle intake anyway
Weve worked on leading GLP-1 trials, including those involving semaglutide (Wegovy), and have over 200 specialist doctors (principal investigators) leading our research studies, supported by a team that has experience in over 35,000 trials globally
In a head-to-head trial in adults with obesity or overweight without diabetes, tirzepatide, the active ingredient in Mounjaro and Zepbound led to greater average weight loss than semaglutide over 72 weeks.However, there are various factors to consider when determining which medication is the best fit for an individual's unique needs including cost and insurance coverage, overall health, side effects, and how well the medication aligns with one's lifestyle and goals
In fact, Wegovy was recently approved to help reduce the risk of major cardiovascular events (like heart attacks and strokes) in adults with cardiovascular disease and obesity